Search Results - "Gagnon, Andre"

Co-pay cards in Canada: Improving choice or institutionalizing bribes? by Gagnon, Marc-André

Get full text

Understanding the Battle for Universal Pharmacare in Canada Comment on "Universal Pharmacare in Canada" by Gagnon, Marc-André

“…Drug coverage in Canada is a patchwork; an inequitable inefficient and unsustainable patchwork with no coherence or purpose. Some people think that we can…”
Get full text

Phase IV Drug Trials With a Canadian Site: A Comparison of Industry-Funded and Non-Industry-Funded Trials by Lexchin, Joel, Dong, Blue Miaoran, Ramanathan, Aravind, Gagnon, Marc-André

“…Recent regulatory reforms have favored expedited drug marketing and increased reliance on Phase IV clinical trials for safety and efficacy assurance. This…”
Get full text

Evaluating the effects of Quebec's private-public drug insurance system by Morgan, Steven G, Gagnon, Marc-André, Charbonneau, Mathieu, Vadeboncoeur, Alain

“…As calls for universal pharmacare across Canada become stronger and models for its delivery are considered, it is worth looking at whether Quebec's current…”
Get full text

Corruption of Pharmaceutical Markets: Addressing the Misalignment of Financial Incentives and Public Health by Gagnon, Marc-André

“…This paper explains how the current architecture of the pharmaceutical markets has created a misalignment of financial incentives and public health that is a…”
Get full text

Poisoning Regulation, Research, Health, and the Environment: The Glyphosate-Based Herbicides Case in Canada by Bacon, Marie-Hélène, Vandelac, Louise, Gagnon, Marc-André, Parent, Lise

“…Despite discourse advocating pesticide reduction, there has been an exponential increase in pesticide use worldwide in the agricultural sector over the last 30…”
Get full text

Merger mania: mergers and acquisitions in the generic drug sector from 1995 to 2016 by Gagnon, Marc-André, Volesky, Karena D

“…Drug shortages and increasing generic drug prices are associated with low levels of competition. Mergers and acquisitions impact the level of competition…”
Get full text

Comparison of the structure and the transport properties of low-set and high-set curdlan hydrogels by Gagnon, Marc-André, Lafleur, Michel

“…Low-set and high-set curdlan gels prepared from the same aqueous suspension. [Display omitted] ► Microscopic structure and the transport properties of low- and…”
Get full text

The cost of pushing pills: a new estimate of pharmaceutical promotion expenditures in the United States by Gagnon, Marc-André, Lexchin, Joel

Get full text

Role of the ammonium group in the diffusion of quaternary ammonium compounds in Streptococcus mutans biofilms by Sandt, Christophe, Barbeau, Jean, Gagnon, Marc-André, Lafleur, Michel

“…Objectives Cetylpyridinium chloride (CPC), a quaternary ammonium compound, was shown to interact irreversibly with Streptococcus mutans biofilms, leading to a…”
Get full text

Achieving greater independence from commercial influence in research by Lexchin, Joel, Bero, Lisa A, Davis, Courtney, Gagnon, Marc-Andre

Get more information

From Curdlan Powder to the Triple Helix Gel Structure: An Attenuated Total Reflection—Infrared Study of the Gelation Process by Gagnon, Marc-André, Lafleur, Michel

“…Infrared spectroscopy was used to probe the hydration and gelation of curdlan, a linear polysaccharide built from repeating units of (1→3)-β-D-glucose. The…”
Get full text

Corrigendum to “Background Radiance Estimation for Gas Plume Quantification for Airborne Hyperspectral Thermal Imaging” by Gagnon, Marc-André, Foucher, Pierre-Yves, Vidal, Thomas H. G., Idoughi, Ramzi, Briottet, Xavier

“…In the article titled “Background Radiance Estimation for Gas Plume Quantification for Airborne Hyperspectral Thermal Imaging” [1], there are some errors in…”
Get full text

Time to improve transparency at Health Canada’s Pest Management Regulatory Agency by Gagnon, Marc-Andre, Bacon, Marie-Helene

“…Last year, Health Canada's Pest Management Regulatory Agency has been criticized for not releasing information about the safety of pesticides because data are…”
Get full text

L’aide financière à l’industrie pharmaceutique québécoise : le jeu en vaut-il la chandelle? by Gagnon, Marc-André

“…The development of Quebec’s pharmaceutical industry is often considered a success story resulting from Quebec’s specific policies supporting industries with…”
Get full text

Whose shoulders is health research standing on? Determining the key actors and contents of the prevailing biomedical research agenda by Testoni, Federico E, García Carrillo, Mercedes, Gagnon, Marc-André, Rikap, Cecilia, Blaustein, Matías

“…Conflicts of interest in biomedical research can influence research results and drive research agendas away from public health priorities. Previous…”
Get full text

Habituation to thaxtomin A increases resistance to common scab in ‘Russet Burbank’ potato by Beaudoin, Nathalie, Isayenka, Iauhenia, Ducharme, Audrey, Massie, Sophie, Gagnon, André, Hogue, Richard, Beaulieu, Carole, Michaud, Dominique

“…Common scab is a potato disease characterized by the formation of scab-like lesions on the surface of potato tubers. The actinobacterium Streptomyces scabiei…”
Get full text

Prevalence and nature of manufacturer-sponsored patient support programs for prescription drugs in Canada: a cross-sectional study by Grundy, Quinn, Quanbury, Ashton, Hart, Dana, Chaudhry, Shanzeh, Tavangar, Farideh, Lexchin, Joel, Gagnon, Marc-Andre, Tadrous, Mina

“…Background: Globally, pharmaceutical companies offer patient support programs in tandem with their products, which aim to enhance medication adherence and…”
Get full text

Capital, Power and Knowledge According to Thorstein Veblen: Reinterpreting the Knowledge-Based Economy by Gagnon, Marc-André

“…Analyzing the American economy at the beginning of the twentieth century, Thorstein Veblen contended that knowledge has always been the main productive…”
Get full text

The role and impact of cost-sharing mechanisms for prescription drug coverage by Gagnon, Marc-André

“…Two linked research studies discuss the impact of cost-sharing mechanisms on cost-related nonadherence to drugs by looking at the introduction of income-based…”
Get full text